Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models

The arachidonic acid (AA) cascade involves the release of AA from the membrane phospholipids by a phospholipase A₂, followed by its subsequent metabolism to bioactive prostanoids by cyclooxygenases coupled with terminal synthases. Altered brain AA metabolism has been implicated in neurological, neur...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 102; no. 3; pp. 577 - 586
Main Author Bosetti, Francesca
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.08.2007
Blackwell Publishing Ltd
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The arachidonic acid (AA) cascade involves the release of AA from the membrane phospholipids by a phospholipase A₂, followed by its subsequent metabolism to bioactive prostanoids by cyclooxygenases coupled with terminal synthases. Altered brain AA metabolism has been implicated in neurological, neurodegenerative, and psychiatric disorders. The development of genetically altered mice lacking specific enzymes of the AA cascade has helped to elucidate the individual roles of these enzymes in brain physiology and pathology. The roles of AA and its metabolites in brain physiology, with a particular emphasis on the phospholipase A₂/cyclooxygenases pathway, are summarized, and the specific phenotypes of genetically altered mice relevant to brain physiology and neurotoxic models are discussed.
Bibliography:http://dx.doi.org/10.1111/j.1471-4159.2007.04558.x
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3042
1471-4159
DOI:10.1111/j.1471-4159.2007.04558.x